Security Snapshot

TELA Bio, Inc. - Class A Common Stock (TELA) Institutional Ownership

CUSIP: 872381108

13F Institutional Holders and Ownership History from Q4 2019 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

44

Shares (Excl. Options)

25.75MFull value: 25,747,187 · shares · 30 Jun 2026

Price

$0.75

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-1,128,002
Value change
-$843,311
Number of holders
44
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
44,525,021
SEC-reported price per share
$1.14
Insider filing price
$1.14
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • TELA - TELA Bio, Inc. - Class A Common Stock is tracked under CUSIP 872381108.
  • 44 institutions reported positions in Q2 2026.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 34 to 44 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $16.6MFull value: $16,599,743 · USD · 31 Mar 2026
    to
    $19.33MFull value: $19,325,165 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 44 institutions filings for Q2 2026.

Open SEC evidence

Security key

872381108

13F reference period

Q2 2026

13F holders

44

13D/G owners

7

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
7
Security
TELA
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
EW HEALTHCARE PARTNERS FUND 2, L.P. 17% -0.53% $7,406,121 7,714,709 0% EW Healthcare Partners Fund 2-GP, L.P. 09 Jun 2026
Nantahala Capital Management, LLC 13% +0.31% $4,751,173 +$559,671 5,794,114 +13% Nantahala Capital Management, LLC 30 Jun 2026
NORTH RUN CAPITAL, LP 9.3% +86% $3,608,839 +$1,666,000 3,682,489 +86% North Run Capital, LP 31 Mar 2025
LYTTON LAURENCE W 5.5% -24% $1,465,405 -$253,778 2,442,341 -15% Lytton, Laurence W. 31 Mar 2026
Stonepine Capital Management, LLC 6% $2,211,913 2,353,099 Stonepine Capital Management, LLC 31 Dec 2024
SILVERARC CAPITAL MANAGEMENT, LLC 4.8% -38% $1,752,505 -$761,327 2,137,201 -30% SilverArc Capital Management, LLC 30 Jun 2026
HIRSCHMAN ORIN 3.6% -46% $1,331,344 -$1,171,674 1,416,323 -47% Orin Hirschman 31 Mar 2025
As of 30 Jun 2026, 44 institutional investors reported holding
25.75MFull value: 25,747,187 · shares · 30 Jun 2026
shares of TELA Bio, Inc. - Class A Common Stock (TELA). This represents 58% of the company’s total
44.53MFull value: 44,525,021 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
58%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Essex Woodlands Management, Inc. 17% 7,714,709 0% 2.3% $5,786,032
Nantahala Capital Management, LLC 13% 5,894,114 +15% 0.27% $4,420,586
Stonepine Capital Management, LLC 6% 2,662,427 +1.7% 1.5% $1,996,820
SILVERARC CAPITAL MANAGEMENT, LLC 4.8% 2,137,201 -5.4% 0.18% $1,602,901
VANGUARD CAPITAL MANAGEMENT LLC 3.5% 1,568,218 +1.8% 0% $1,176,164
DAFNA Capital Management LLC 3.2% 1,441,029 0% 0.21% $1,080,772
PERKINS CAPITAL MANAGEMENT INC 3.1% 1,375,042 -3.1% 0.78% $1,031,281
Sio Capital Management, LLC 1.4% 636,300 0% 0.08% $477,225
WealthTrust Axiom LLC 1% 457,734 +21% 0.08% $343,300
GEODE CAPITAL MANAGEMENT, LLC 0.87% 389,223 -14% 0% $291,952
BlackRock, Inc. 0.84% 374,516 -20% 0% $280,887
VANGUARD FIDUCIARY TRUST CO 0.48% 213,138 +0.7% 0% $159,854
UP STRATEGIC WEALTH INVESTMENT ADVISORS LLC 0.22% 99,888 0% 0.05% $91,398
Embree Financial Group 0.2% 90,906 -23% 0.01% $68,180
NORTHERN TRUST CORP 0.17% 74,790 -57% 0% $56,093
RAYMOND JAMES FINANCIAL INC 0.15% 67,700 +36% 0% $50,775
STATE STREET CORP 0.14% 63,383 0% 0% $47,537
RENAISSANCE TECHNOLOGIES LLC 0.13% 58,100 +10% 0% $43,575
PNC Financial Services Group, Inc. 0.12% 53,612 0% 0% $40,209
Destiny Wealth Partners, LLC 0.12% 52,500 0% 0.01% $38,320
Ducere Wealth Management LLC 0.11% 51,000 +24% 0.01% $38,250
JANE STREET GROUP, LLC 0.11% 49,245 0% $36,933
UBS Group AG 0.08% 33,466 -97% 0% $25,100
XTX Topco Ltd 0.07% 29,558 +95% 0% $22,169
TD Waterhouse Canada Inc. 0.05% 23,000 0% $16,560

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
28
Headline period
Q2 2026
Rows shown
1-25 of 28
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 2,308,266 $2,625,805 +$767,411 $1.15 8
2026 Q2 25,747,187 $19,325,165 -$843,311 $0.75 44
2026 Q1 26,775,305 $16,599,743 -$516,766 $0.62 34
2025 Q4 27,581,886 $32,498,316 +$4,151,171 $1.18 41
2025 Q3 23,562,953 $35,108,965 +$70,979 $1.49 40
2025 Q2 23,475,441 $45,542,765 -$775,817 $1.94 45
2025 Q1 24,589,431 $30,000,578 -$5,393,768 $1.22 47
2024 Q4 27,032,996 $81,640,185 +$27,788,571 $3.02 46
2024 Q3 18,012,190 $45,588,967 -$10,956,793 $2.53 48
2024 Q2 19,879,104 $93,430,843 -$6,702,626 $4.70 67
2024 Q1 20,686,484 $117,292,014 -$1,655,166 $5.67 58
2023 Q4 20,961,753 $138,767,513 -$8,011,684 $6.62 59
2023 Q3 21,852,278 $174,816,904 -$1,837,658 $8.00 66
2023 Q2 22,055,151 $223,420,734 +$51,494,354 $10.13 67
2023 Q1 16,939,491 $180,199,912 -$5,749,423 $10.64 54
2022 Q4 17,430,212 $200,446,271 +$6,246,137 $11.50 49
2022 Q3 16,786,563 $143,023,324 +$28,855,257 $8.52 43
2022 Q2 13,534,368 $95,028,004 +$13,917,248 $7.01 31
2022 Q1 11,160,859 $129,798,000 +$6,753,935 $11.63 29
2021 Q4 10,531,506 $134,807,000 -$160,970 $12.80 34
2021 Q3 10,239,091 $139,838,000 -$320,790 $13.66 35
2021 Q2 10,239,149 $164,948,850 +$6,022,396 $16.11 43
2021 Q1 9,891,266 $147,387,000 +$2,988,786 $14.90 46
2020 Q4 9,690,658 $145,766,000 -$988,972 $15.04 47
2020 Q3 9,752,756 $161,293,000 +$2,115,756 $16.54 43
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .